Negative symptom configuration in first episode Schizophrenia: findings from the “Parma Early Psychosis” program

References

• Bleuler E. Dementia praecox oder gruppe der schizophrenien. Leipzig (Germany): Deuticke; 1911.
   Google Scholar
• Galderisi S, Farden A, Kaiser S. Dissecting negative symptoms of schizophrenia: history, assessment, pathophysiological mechanisms and treatment. Schizophr Res. 2017;186:1–2.
   PubMed Web of Science ®Google Scholar
• Lorenzo P, Silvia A, Federica P, et al. The Italian version of the 16-item prodromal questionnaire (iPQ-16): field-test and psychometric features. Schizophr Res. 2018;199:353–360.
   PubMed Web of Science ®Google Scholar
• Poletti M, Pelizza L, Azzali S, et al. Clinical high risk for psychosis in childhood and adolescence: findings from the 2-year follow-up of the ReARMS project. Eur Child Adolesc Psychiatry. 2019;28(7):957–971.
   PubMed Web of Science ®Google Scholar
• McGorry PD, Nelson B, Amminger GP, et al. Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry. 2009;70(9):1206–1212.
   PubMed Web of Science ®Google Scholar
• Pelizza L, Azzali S, Garlassi S, et al. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate. Eur Child Adolesc Psychiatry. 2018;27(6):725–737.
   PubMed Web of Science ®Google Scholar
• Tibber MS, Kirkbride JB, Joyce EM, et al. The component structure of the scales for the assessment of positive and negative symptoms in first-episode psychosis and its dependence on variations in analytic methods. Psychiatry Res. 2018;270:869–879.
   PubMed Web of Science ®Google Scholar
• Blanchard JJ, Cohen AS. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull. 2006;32(2):238–245.
   PubMed Web of Science ®Google Scholar
• Galderisi S, Mucci A, Buchanan RW, et al. Negative symptoms of schizophrenia: new developments and unanswered research questions. Lancet Psychiatry. 2018;5(8):664–677.
   PubMed Web of Science ®Google Scholar
• Strauss GP, Esfahlani FZ, Galderisi S, et al. Network analysis reveals the latent structure of negative symptoms in schizophrenia. Schizophr Bull. 2019;45(5):1033–1041.
   PubMed Web of Science ®Google Scholar
• Galderisi S, Bucci P, Mucci A, et al. Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. Schizophr Res. 2013;147(1):157–162.
   PubMed Web of Science ®Google Scholar
• Ventura J, Subotnik KL, Gitlin MJ, et al. Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later. Schizophr Res. 2015;161(2–3):407–413.
   PubMed Web of Science ®Google Scholar
• Pelizza L, Azzali S, Paterlini F, et al. The Italian version of the brief 21-item Prodromal Questionnaire: field test, psychometric properties and age-sensitive cut-offs. Psychopathology. 2018;51(4):234–244.
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276.
   PubMed Web of Science ®Google Scholar
• Leuci E, Damini C, Ceroni P, et al. PDTA aziendale “Esordi Psicotici. Parma (Italy): Centro Stampa dell’AUSL di Parma; 2019.
   Google Scholar
• American Psychiatric Association (APA). Diagnostic and Statistical Manual of mental disorders, IV edition, Text Revised (DSM-IV-TR). Washington (DC): APA Press; 2000.
   Google Scholar
• Ran MS, Xiao Y, Chui CHK, et al. Duration of untreated psychosis (DUP) and outcome of people with schizophrenia in rural China: 14-year follow-up study. Psychiatry Res. 2018;267:340–345.
   PubMed Web of Science ®Google Scholar
• Yung AR, Yuen HP, McGorry PD, et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry. 2005;39(11–12):964–971.
   PubMed Web of Science ®Google Scholar
• Pancheri P, Brugnoli R, Carilli L, et al. Valutazione dimensionale della sintomatologia schizofrenica: validazione della versione italiana della Scala per la valutazione dei Sintomi Positivi e Negativi (PANNS). G It Psicopatol. 1995;1:60–75.
   Google Scholar
• Pelizza L, Azzali S, Paterlini F, et al. Screening for psychosis risk among help-seeking adolescents: application of the Italian version of the 16-item prodromal questionnaire (iPQ-16) in child and adolescent neuropsychiatry services. Early Interv Psychiatry. 2019;13(4):752–760.
   PubMed Web of Science ®Google Scholar
• Pelizza L, Raballo A, Semrov E, et al. Validation of the “early detection Primary Care Checklist” in an Italian community help-seeking sample: the “checklist per la Valutazione dell'Esordio Psicotico. Early Interv Psychiatry. 2019;13(1):86–94.
   PubMed Web of Science ®Google Scholar
• Emsley R, Rabinowitz J, Torreman M. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr Res. 2003;61(1):47–57.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim SY, Lee J, et al. Evaluation of the factor structure of symptoms in patients with schizophrenia. Psychiatry Res. 2012;197(3):285–289.
   PubMed Web of Science ®Google Scholar
• Higuchi CH, Ortiz B, Berberian AA, et al. Factor structure of the Positive and Negative Syndrome Scale (PANSS) in Brazil: convergent validation of the Brazilian version. Rev Bras Psiquiatr. 2014;36(4):336–339.
   PubMed Web of Science ®Google Scholar
• Khan A, Lindenmayer JP, Opler M, et al. A new integrated negative symptom structure of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia using item response analysis. Schizophr Res. 2013;150(1):185–196.
   PubMed Web of Science ®Google Scholar
• Lyne J, Renwick L, Grant T, et al. Scale for the Assessment of Negative Symptoms structure in first episode psychosis. Psychiatry Res. 2013;210(3):1191–1197.
   PubMed Web of Science ®Google Scholar
• Khan A, Liharska L, Harvey PD, et al. Negative symptom dimensions of the Positive and Negative Syndrome Scale across geographical regions: implications for social, linguistic, and cultural consistency. Innov Clin Neurosci. 2017;14(11–12):30–40.
   PubMedGoogle Scholar
• Andreoli V, Cassano GB, Rossi R. DSM-IV-TR: Manuale diagnostico e statistico dei disturbi mentali, IV Edizione, Text Revision. Milano (Italy): Masson; 2007.
   Google Scholar
• Paterlini F, Pelizza L, Galli G, et al. Interrater reliability of the authorized Italian version of the Comprehensive Assessment of At-Risk Mental States (CAARMS-ITA). J Psychopathol. 2019;25:24–28.
   Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR axis I Disorders (SCID-I). New York, NY: New York State Psychiatric Institute; 2002.
   Google Scholar
• SPSS Inc. Statistical Package for Social Science (SPSS) for Windows, version 15.0. Chicago (IL): SPSS Inc. Press; 2010.
   Google Scholar
• R Core Team. R: a language and environment for statistical computing. Wien (Austria): R Foundation for Statistical Computing; 2014.
   Google Scholar
• Revelle W. Psych: procedures for psychological, psychometric, and personality research. Evanston, IL: Northwestern University Press; 2018.
   Google Scholar
• Rosseel Y. Lavaan: an R package for structural equation modeling. J Stat Softw. 2012;48:1–36.
   Web of Science ®Google Scholar
• Andreasen NC. Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry. 1982;39(7):784–788.
   PubMed Web of Science ®Google Scholar
• Jang SK, Choi HI, Park S, et al. A two-factor model better explains heterogeneity in negative symptoms: evidence from the Positive and Negative Syndrome Scale. Front Psychol. 2016;7:707.
   PubMed Web of Science ®Google Scholar
• Brown TA. Confirmatory factor analysis for applied research. 2nd ed. New York (NY): The Guilford Press; 2015.
   Google Scholar
• Hu L, Bentler PM. Cut-off criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model Multidiscip J. 1999;6(1):1–55.
   Web of Science ®Google Scholar
• Fabrigar L, Wegener D, MacCallum R, et al. Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods. 1999;4(3):272–299.
   Web of Science ®Google Scholar
• Marsh HW, Morin AJ, Parker PD, et al. Exploratory structural equation modeling: an integration of the best features of exploratory and confirmatory factor analysis. Annu Rev Clin Psychol. 2014;10(1):85–110.
   PubMed Web of Science ®Google Scholar
• Hair J, Anderson R, Tatham W, et al. Multivariate data analysis. 5th ed. London (UK): Prentice Hall International; 1998.
   Google Scholar
• Holm SA. A simple sequentially rejective multiple test procedure. Scandinavian J Stat. 1979;6:65–70.
   Web of Science ®Google Scholar
• Marder SR, Galderisi S. The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 2017;16(1):14–24.
   PubMed Web of Science ®Google Scholar
• Liemburg E, Castelein S, Stewart R, et al. Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts. J Psychiatr Res. 2013;47(6):718–725.
   PubMed Web of Science ®Google Scholar
• Azzali S, Pelizza L, Paterlini F, et al. Reliability of the Italian version of the 16-item Prodromal Questionnaire (iPQ-16) for psychosis risk screening in a young help-seeking community sample. J Psychopathol. 2018;24:16–23.
   Web of Science ®Google Scholar
• Kring AM, Moran EK. Emotional response deficits in schizophrenia: insights from affective science. Schizophr Bull. 2008;34(5):819–834.
   PubMed Web of Science ®Google Scholar
• Walther S, Stegmayer K, Sulzbacher J, et al. Nonverbal social communication and gesture control in schizophrenia. Schizophr Bull. 2015;41(2):338–345.
   PubMed Web of Science ®Google Scholar
• Sayers SL, Curran PJ, Mueser KT. Factor structure and construct validity of the Scale for the Assessment of Negative Symptoms. Psychol Assess. 1996;8(3):269–289.
   Web of Science ®Google Scholar
• Berenbaum H, Kerns JG, Vernon LL, et al. Cognitive correlates of schizophrenia signs and symptoms: I. Verbal communication disturbances. Psychiatry Res. 2008;159(1–2):147–156.
   PubMed Web of Science ®Google Scholar
• Fervaha G, Takeuchi H, Foussias G, et al. Using poverty of speech as a case study to explore the overlap between negative symptoms and cognitive dysfunction. Schizophr Res. 2016;176(2–3):411–416.
   PubMed Web of Science ®Google Scholar
• Docherty AR, Berenbaum H, Kerns JG. Alogia and formal thought disorder: differential patterns of verbal fluency task performance. J Psychiatr Res. 2011;45(10):1352–1357.
   PubMed Web of Science ®Google Scholar
• Cohen AS, McGovern JE, Dinzeo TJ, et al. Speech deficits in serious mental illness: a cognitive resource issue? Schizophr Res. 2014;160(1–3):173–179.
   PubMed Web of Science ®Google Scholar
• Pelizza L, Azzali S, Paterlini F, et al. The “Reggio Emilia At-Risk Mental States” program: a diffused, “liquid” model of early intervention in psychosis implemented in an Italian Department of Mental Health. Early Interv Psychiatry. 2019;13(6):1513–1524.
   PubMed Web of Science ®Google Scholar
• Salamone JD, Yohn SE, Lopez-Cruz L, et al. Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology. Brain. 2016;139(5):1325–1347.
   PubMed Web of Science ®Google Scholar
• Ahmed AO, Kirkpatrick B, Galderisi S, et al. Cross-cultural validation of the 5-factor structure of negative symptoms in schizophrenia. Schizophr Bull. 2019;45(2):305–314.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick B, Strauss GP, Nguyen L, et al. The brief negative symptom scale: psychometric properties. Schizophr Bull. 2011;37(2):300–305.
   PubMed Web of Science ®Google Scholar
• Gehr J, Glenthoj B, Nielsen MO. Validation of the Danish version of the Brief Negative Symptom scale. Nordic J Psychiatry. 2019;73(7):425–432.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (APA). Diagnostic and Statistical Manual of mental disorders. 5th ed. (DSM-5). Washington DC: APA Press; 2013.
   Google Scholar
• Suzuki T, Uchida H, Nomura K, et al. Novel rating scales for schizophrenia: Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz). Schizophr Res. 2008;106(2–3):328–336.
   PubMed Web of Science ®Google Scholar
• Sukuzi T. Which rating scales are regarded as “the standard” in clinical trials for schizophrenia? A critical review. Psychopharmacol Bull. 2011;44(1):18–31.
   PubMedGoogle Scholar